Amgen stock approaches Q3 report as webcast details stand
Published on 11/03/2026 at 13:17 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAmgen approaches its quarterly report
- Amgen will publish third-quarter 2026 results after the U.S. market close on Tuesday.
- Chief Executive Robert Bradway and senior management are scheduled to join the investor call.
- The webcast will remain available for replay for at least 90 days.
Amgen will release its third-quarter 2026 financial results after the U.S. market close on Tuesday, November 3, the company said in an October 28 release published by Amgen Investor Relations. The announcement sets an immediate reporting date for investors tracking the biotechnology groups pipeline, product demand and full-year outlook.
The results will be followed by a conference call at 4:30 p.m. Eastern Time with Chief Executive Robert A. Bradway, chairman and chief executive officer, and other members of Amgens senior management. The company said the live audio webcast will be available to investors, the media and the general public.
What investors will hear next
Managements comments will be central to the market assessment because the call is scheduled immediately after the results release. Investors will be able to review the webcast later, with Amgen stating that the recording will remain available for at least 90 days.
Amgen stock traded at 415.60 euros on Lang & Schwarz at 1:11 p.m. CET on Tuesday, November 3. Investors can follow the real-time quote of Amgen stock.
Amgen stock at a glance
- Company: Amgen Inc.
- ISIN: US0311621009
- Ticker: AMGN
- Home exchange: Nasdaq
- Lang & Schwarz price: 415.60 euros at 1:11 p.m. CET on Tuesday, November 3, 2026
The broader U.S. market can be followed through current S&P 500 market coverage.
Further reporting on the scheduled results, management commentary and subsequent developments is available in more news and analyses on Amgen stock.
